AGEN
Price
$2.71
Change
-$0.11 (-3.90%)
Updated
Apr 25, 04:59 PM (EDT)
Capitalization
71.37M
SGMO
Price
$0.78
Change
-$0.03 (-3.70%)
Updated
Apr 25, 04:59 PM (EDT)
Capitalization
183.12M
5 days until earnings call
Ad is loading...

AGEN vs SGMO

Header iconAGEN vs SGMO Comparison
Open Charts AGEN vs SGMOBanner chart's image
Agenus
Price$2.71
Change-$0.11 (-3.90%)
Volume$1.78K
Capitalization71.37M
Sangamo Therapeutics
Price$0.78
Change-$0.03 (-3.70%)
Volume$14.63K
Capitalization183.12M
AGEN vs SGMO Comparison Chart
Loading...
AGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AGEN vs. SGMO commentary
Apr 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGEN is a Buy and SGMO is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 26, 2025
Stock price -- (AGEN: $2.82 vs. SGMO: $0.81)
Brand notoriety: AGEN and SGMO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGEN: 130% vs. SGMO: 83%
Market capitalization -- AGEN: $71.37M vs. SGMO: $183.12M
AGEN [@Biotechnology] is valued at $71.37M. SGMO’s [@Biotechnology] market capitalization is $183.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGEN’s FA Score shows that 0 FA rating(s) are green whileSGMO’s FA Score has 0 green FA rating(s).

  • AGEN’s FA Score: 0 green, 5 red.
  • SGMO’s FA Score: 0 green, 5 red.
According to our system of comparison, AGEN is a better buy in the long-term than SGMO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGEN’s TA Score shows that 4 TA indicator(s) are bullish while SGMO’s TA Score has 4 bullish TA indicator(s).

  • AGEN’s TA Score: 4 bullish, 5 bearish.
  • SGMO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SGMO is a better buy in the short-term than AGEN.

Price Growth

AGEN (@Biotechnology) experienced а +35.58% price change this week, while SGMO (@Biotechnology) price change was +15.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.20%. For the same industry, the average monthly price growth was -4.19%, and the average quarterly price growth was -12.04%.

Reported Earning Dates

AGEN is expected to report earnings on Mar 17, 2025.

SGMO is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+7.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SGMO($183M) has a higher market cap than AGEN($71.4M). AGEN YTD gains are higher at: 2.920 vs. SGMO (-20.108). AGEN has higher annual earnings (EBITDA): -77.64M vs. SGMO (-123.99M). AGEN has more cash in the bank: 44.8M vs. SGMO (39.2M). SGMO has less debt than AGEN: SGMO (27.7M) vs AGEN (78.4M). AGEN has higher revenues than SGMO: AGEN (160M) vs SGMO (52.3M).
AGENSGMOAGEN / SGMO
Capitalization71.4M183M39%
EBITDA-77.64M-123.99M63%
Gain YTD2.920-20.108-15%
P/E Ratio0.46N/A-
Revenue160M52.3M306%
Total Cash44.8M39.2M114%
Total Debt78.4M27.7M283%
FUNDAMENTALS RATINGS
AGEN vs SGMO: Fundamental Ratings
AGEN
SGMO
OUTLOOK RATING
1..100
2728
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
64
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10096
PRICE GROWTH RATING
1..100
4164
P/E GROWTH RATING
1..100
94100
SEASONALITY SCORE
1..100
65n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SGMO's Valuation (64) in the Biotechnology industry is somewhat better than the same rating for AGEN (97). This means that SGMO’s stock grew somewhat faster than AGEN’s over the last 12 months.

SGMO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as AGEN (100). This means that SGMO’s stock grew similarly to AGEN’s over the last 12 months.

SGMO's SMR Rating (96) in the Biotechnology industry is in the same range as AGEN (100). This means that SGMO’s stock grew similarly to AGEN’s over the last 12 months.

AGEN's Price Growth Rating (41) in the Biotechnology industry is in the same range as SGMO (64). This means that AGEN’s stock grew similarly to SGMO’s over the last 12 months.

AGEN's P/E Growth Rating (94) in the Biotechnology industry is in the same range as SGMO (100). This means that AGEN’s stock grew similarly to SGMO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AGENSGMO
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
AGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FTCI3.130.31
+10.99%
FTC Solar
NFLX1096.8747.28
+4.50%
Netflix
IVZ14.070.56
+4.15%
Invesco Ltd
PHIN44.011.33
+3.12%
PHINIA
CCNE22.140.41
+1.89%
CNB Financial Corp

AGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AGEN has been closely correlated with SNPX. These tickers have moved in lockstep 91% of the time. This A.I.-generated data suggests there is a high statistical probability that if AGEN jumps, then SNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGEN
1D Price
Change %
AGEN100%
-1.05%
SNPX - AGEN
91%
Closely correlated
+1.32%
ALLR - AGEN
87%
Closely correlated
+5.94%
NRXP - AGEN
83%
Closely correlated
+4.55%
PALI - AGEN
81%
Closely correlated
+3.94%
AXON - AGEN
42%
Loosely correlated
+2.39%
More

SGMO and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGMO has been loosely correlated with AXON. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if SGMO jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGMO
1D Price
Change %
SGMO100%
+8.06%
AXON - SGMO
51%
Loosely correlated
+2.39%
ARRY - SGMO
48%
Loosely correlated
+5.31%
BCRX - SGMO
46%
Loosely correlated
+3.27%
RPRX - SGMO
45%
Loosely correlated
+1.07%
AGEN - SGMO
43%
Loosely correlated
-1.05%
More